JOAN ZIMMER: Open Payments
NPI 1437343746 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,752 in 73 payments from 28 companies in 2025. Trend: 2023 $2,212 · 2024 $1,985 · 2025 $1,752
Food & beverage: $1,752
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $223 |
| AstraZeneca Pharmaceuticals LP | 7 | $152 |
| Lilly USA, LLC | 4 | $105 |
| Radius Health, Inc. | 1 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Novo Nordisk Inc | 4 | $89 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| Lundbeck LLC | 4 | $83 |
| Antares Pharma, Inc. | 4 | $82 |
Products named: REXULTI, UBRELVY, AIRSUPRA, LEQVIO, Auvelity, XYOSTED, Ozempic, CAPLYTA.
Industry payments across WA — which companies pay providers there.
